For the Inventor, By the Inventor

Enter assignee name

San Carlos, CA, United States of America

Apexigen, Inc.

USPTO Granted Patents = 14

% Expired Patents = 21.4

EPO Patents = 6

Trademarks = 1

Forward Citations = 57

Loading Chart...

Loading Chart...

13 inventors (with patents filed for the assignee):

Yongke Zhang (13 out of 14 patents)

Weimin Zhu (10 out of 19 patents)

Guo-Liang Yu (9 out of 142 patents)

4. Yaohuang Ke (5 out of 16 patents)

5. Sum Wai Pierre Lee (4 out of 4 patents)

6. Xiaodong Yang (2 out of 3 patents)

7. Pia Björck (1 out of 1 patent)

8. Christine Tan (1 out of 5 patents)

9. Erin Filbert (1 out of 1 patent)

10. Pierre Li (1 out of 1 patent)

11. Guoliang Yu (1 out of 1 patent)

12. Fanxin Ma (1 out of 1 patent)

13. Xin Fan (1 out of 1 patent)

14 patents: Sort by Forward Citations

1. 11078283 - Anti-PD-L1 antibodies and methods of use (2021-08-03),

2. 11001637 - Anti-CD40 antibodies (2021-05-11),

3. 10259878 - Anti-RANKL antibodies and methods of use (2019-04-16),

4. 9994640 - Anti-CD40 antibodies (2018-06-12),

5. 9951136 - Anti-IL-6 receptor antibodies and methods of use (2018-04-24),

6. 9676861 - Anti-CD40 antibodies and methods of use (2017-06-13),

7. 9556278 - Anti-CD40 antibodies (2017-01-31),

8. 9441042 - Anti-KDR antibodies and methods of use (2016-09-13),

9. 9266956 - Methods of inhibiting proliferation of CD40-expressing cancer cells with anti-CD40 antibodies (2016-02-23),

10. 9085621 - Anti-IL-1β antibodies (2015-07-21),

11. 8986692 - Anti-VEGF monoclonal antibody and pharmaceutical composition comprising said antibody (2015-03-24),

12. 8957193 - Polynucleotides encoding anti-CD40 antibodies (2015-02-17),

13. 8778345 - Anti-CD40 antibodies (2014-07-15),

14. 8753634 - Anti-IL-6 receptor antibodies and methods of use (2014-06-17),

Apexigen is a clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough antibody-based therapeutics for the treatment of life-threatening diseases. With a focus on oncology, Apexigen utilizes their proprietary antibody technology platform to create next-generation antibody therapeutics that target specific disease pathways. By leveraging their expertise in antibody discovery, optimization, and engineering, Apexigen aims to deliver innovative treatments that improve patient outcomes and address unmet medical needs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

14 Patents

#28 in San Carlos, CA

#5,305 in California

#22,262 in US

#42,118 in the World

San Carlos, CA, United States of America

Apexigen, Inc.

Forward Citations = 57

13 inventors:

Yongke Zhang (13 out of 14 patents)

Weimin Zhu (10 out of 19 patents)

Guo-Liang Yu (9 out of 142 patents)

4. Yaohuang Ke (5 out of 16 patents)

5. Sum Wai Pierre Lee (4 out of 4 patents)

Please report any incorrect information to [email protected]

Loading…